LHX5 and glioblastoma: The results showed that only LHX5 and TLX1 had significant value in predicting the survival rates of patients with GBM; patients with low expression levels of LHX5 and TLX1 had a lower survival rate than those with high expression levels of LHX5 and TLX1 (Figure 7).